 efficaci toler CV dopaminerg drug macroprolactinoma patient prolactinoma patient effect CV patient macroprolactinoma patient prl-secret tumor previou intoler small dose serum insulin-lik growth factor-i igf-i level CV therapi macroprolactinoma patient yr mg CV prl level patient transient side-effect nausea dizzi fatigu patient prl-secret tumor bromocriptin intoler CV mg prl level patient transient side-effect nausea fatigu and/or tachycardia none patient close correl pretreat prl level tumor size cubic millimet decreas pituitari tumor size week CV therapi decreas prl level patient hypopituitar igf-i level CV therapi untreat patient macroprolactinoma normal CV potent dopaminerg drug prl secret induc tumor shrinkag dose studi mild transient side-effect minor patient hyperprolactinem patient intoler therapi